Abstract
Background
Familial papillary thyroid carcinoma (familial PTC) is well known to present with aggressiveness; however, the characteristics and the prognostic outcomes of familial papillary thyroid microcarcinoma (familial micro-PTC) are not well established. The overall aim of this study was to analyze the clinicopathological outcomes of familial micro-PTC.
Methods
Between 1996 and 2006, 2071 patients underwent thyroid surgery for papillary thyroid carcinoma. The clinicopathological outcomes for familial PTC and sporadic PTC were compared, and familial micro-PTC data were sub-analyzed.
Results
There were significant differences in multifocality, bilaterality, extent of surgery, and recurrence between familial PTC and sporadic PTC (p < 0.05). There was no significant difference in the number of affected family members in the familial PTC group. In patients with familial micro-PTC, less aggressiveness was noted in multifocality, extrathyroidal invasion, tumor stage at time of initial surgery, central lymph node metastasis, and recurrence than in those with familial PTC tumors >1 cm in diameter (p < 0.05). The multivariate analysis including recurrence showed no significant difference between familial micro-PTC patients and sporadic micro-PTC patients.
Conclusion
When familial PTC was compared with sporadic PTC, our results support the recommendation for more invasive familial PTC surgery. However, familial micro-PTC outcomes differed from familial PTC tumors >1.0 cm in diameter. It was similar to sporadic micro-PTC, illustrating that familial micro-PTC is less aggressive and that a less invasive surgical treatment could be considered.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sherman SI (2003) Thyroid carcinoma. Lancet 361:501–511
Grodski S, Delbridge L (2009) An update on papillary microcarcinoma. Curr Opin Oncol 21:1–4
Grodski S, Brown T, Sidhu S et al (2008) Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery 144:1038–1043 discussion 1043
Schlumberger MJ (1998) Papillary and follicular thyroid carcinoma. N Engl J Med 338:297–306
Uchino S, Noguchi S, Yamashita H et al (2004) Detection of asymptomatic differentiated thyroid carcinoma by neck ultrasonographic screening for familial nonmedullary thyroid carcinoma. World J Surg 28:1099–1102. doi:10.1007/s00268-004-7676-x
Robinson DW DW, Orr TG (1955) Carcinoma of the thyroid and other diseases of the thyroid in identical twins. AMA Arch Surg 70:923–928
Grossman RF, Tu SH, Duh QY et al (1995) Familial nonmedullary thyroid cancer. An emerging entity that warrants aggressive treatment. Arch Surg 130:892–897 discussion 898–899
DeLellis RA (2006) Pathology and genetics of thyroid carcinoma. J Surg Oncol 94:662–669
Dotto J, Nose V (2008) Familial thyroid carcinoma: a diagnostic algorithm. Adv Anat Pathol 15:332–349
Alsanea O, Wada N, Ain K et al (2000) Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series. Surgery 128:1043–1050 discussion 1050–1041
Uchino S, Noguchi S, Kawamoto H et al (2002) Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population. World J Surg 26:897–902. doi:10.1007/s00268-002-6615-y
Sturgeon C, Clark OH (2005) Familial nonmedullary thyroid cancer. Thyroid 15:588–593
Sippel RS, Caron NR NR (2007) An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up. World J Surg 31:924–933. doi:10.1007/s00268-006-0847-1
Triponez F, Wong M, Sturgeon C et al (2006) Does familial non-medullary thyroid cancer adversely affect survival? World J Surg 30:787–793. doi:10.1007/s00268-005-0398-x
Maxwell EL, Hall FT, Freeman JL (2004) Familial non-medullary thyroid cancer: a matched-case control study. Laryngoscope 114:2182–2186
Ito Y, Kakudo K, Hirokawa M et al (2009) Biological behavior and prognosis of familial papillary thyroid carcinoma. Surgery 145:100–105
Moses W, Weng J, Kebebew E (2011) Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer. Thyroid 21:367–371
Besic N, Pilko G, Petric R et al (2008) Papillary thyroid microcarcinoma: prognostic factors and treatment. J Surg Oncol 97:221–225
Bernet V (2010) Approach to the patient with incidental papillary microcarcinoma. J Clin Endocrinol Metab 95:3586–3592
Lupoli G, Vitale G, Caraglia M et al (1999) Familial papillary thyroid microcarcinoma: a new clinical entity. Lancet 353:637–639
Alsanea O, Clark OH (2001) Familial thyroid cancer. Curr Opin Oncol 13:44–51
Capezzone M, Marchisotta S, Cantara S et al (2008) Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. Endocr Relat Cancer 15:1075–1081
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sung, TY., Lee, Ym., Yoon, J.H. et al. Surgical Management of Familial Papillary Thyroid Microcarcinoma: A Single Institution Study of 94 Cases. World J Surg 39, 1930–1935 (2015). https://doi.org/10.1007/s00268-015-3064-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-015-3064-y